Vertaling van "screening of women " (Nederlands → Frans) :

TERMINOLOGIE

screening van zuigeling voorafgaand aan ontslag
dépistage d'un nourrisson avant la sortie de l'hôpital

screening naar alcoholmisbruik
dépistage d'une surconsommation d'alcool

screening naar middelenmisbruik
dépistage d'une surconsommation de substances

screening naar gehoorverlies
dépistage d'une perte d'audition

screening naar drugmisbruik
dépistage d'une surconsommation de drogues

screening naar ontwikkeling van kind
dépistage du développement d'un enfant

screening naar misbruik
dépistage d'une maltraitance

screening naar depressie
dépistage de la dépression

screening naar immunisatiestatus
dépistage de l'état de l'immunisation

screening naar ontwikkeling van zuigeling
dépistage du développement du nourrisson

IN-CONTEXT TRANSLATIONS

Gerard et al. Women from UK aged 40-64 (1999) 83 EQ-5D years (eligible for screening) UK tariffs (general population) True negative 0.940 At the breast screening Most women are nervous, but are not anxious or depressed. clinic
At the breast screening Most women are nervous, but are not anxious or depressed. Gerard et al. Women from UK aged 40-64

Biopsy rates are higher among women aged 70 to 79 years (12.2 per 1000 women per screening round) than among younger women.
Additional diagnostic tests Rates of additional imaging are relatively low among women aged 70 to 79 years (64.03 per 1000 women per screening round).

The incidence rate in unscreened women can be observed, as in the control group of a randomised trial, or it can be estimated on the basis of the incidence before screening or in other populations not offered screening 10 .
The incidence rate in unscreened women can be observed, as in the control group of a randomised trial, or it can be estimated on the basis of the incidence before screening or in other populations not offered screening 11 .

Rates of additional imaging are relatively low among women aged 70 to 79 years (64.03 per 1000 women per screening round).
screening round). Conversely, false-negative mammography results are a little more common among women aged 70 to 79 years (1.5 per 1000 women per screening round).

39. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography.
40. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography.

Table 8: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)
Table 10: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Relative risks (intention to treat) with confidence reported for each study together with the results of a stepwise meta-analysis and cumulative CI Study ID Relative risk Confidence interval Cumulative RR Cumutlative CI UK Age Trial (UK) 0,83 (0,66-1,04) 0,83 (0,66-1,04) NBSS-1 (Canada) 0,97 (0,74-1,27) 0,89 (0,75-1,06) Malmö (Sweden) (0,58-1,77) 0,9 (0,76-1,06) Stockholm (Sweden) 1,08 (0,54-2,17) 0,91 (0,77-1,07) Göteborg (Sweden) 0,65 (0,40-1,05) 0,87 (0,75-1,02) HIP (USA) 0,75 (0,50-1,11) 0,86 (0,74-0,99) TCS (Sweden) 0,93 (0,63-1,36) 0,86 (0,75-0,99) Edinburgh (UK) 0,75 (0.48-1,18) 0,85 (0,75-0,97)

Table 9: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Crude RR and and RR adjusted following Cuzick (1997) 21 Study ID study
Table 11: Evidence form HTA review : Breast cancer screening among women aged 40 – 49 Crude RR and and RR adjusted following Cuzick (1997) 22 Study ID study